8-KThe WireRed Alert
Executive Change
Filed Jun 5, 2026 · 28d ago · Accession 0001193125-26-259488
Plain English
DBV Technologies S.A. approved the 2026 Performance Share Unit Plan and granted performance share units to its CEO, Daniel Tassé, with vesting tied to FDA approval of Viaskin Peanut. The grant date was June 5, 2026, and the vesting date is July 1, 2028.
Filing details
- Company
- DBV Technologies S.A.
- Ticker
- DBVT
- CIK
- 1613780
- Form type
- 8-K
- Filing date
- Jun 5, 2026
- Report date
- Jun 3, 2026
- Document
- d139789d8k.htm
- Size
- 190 KB